Actinium Pharma is on course to submit its targeted radiotherapy for acute myeloid leukaemia (AML) patients needing a bone marrow transplant in the US, buoyed by top-line data from a pivotal trial.

January's FDA oncology approvals offer new treatment options for breast cancer, mantle cell lymphoma, and other malignancies.

The following is a summary of “Protocol of a decisional intervention for older adults with newly diagnosed acute myeloid ...

An eye for detail is critical for identifying red flags and reporting suspicious activities in accordance with regulations. AML professionals rely on advanced software for transaction monitoring ...